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Polymerase basic protein 1 (PB1), the catalytic core of the influenza A virus RNA
polymerase complex, is essential for viral transcription and replication. Dendritic cells
(DCs) possess important antigen presenting ability and a crucial role in recognizing
and clearing virus. MicroRNA (miRNA) influence the development of DCs and their
ability to present antigens as well as the ability of avian influenza virus (AIV) to infect
host cells and replicate. Here, we studied the molecular mechanism underlying the
miRNA-mediated regulation of immune function in mouse DCs. We first screened for
and verified the induction of miRNAs in DCs after PB1 transfection. Results showed
that the viral protein PB1 down-regulated the expression of miR375, miR146, miR339,
and miR679 in DCs, consistent with the results of H9N2 virus treatment; however, the
expression of miR222 and miR499, also reduced in the presence of PB1, was in contrast
to the results of H9N2 virus treatment. Our results suggest that PB1 enhanced the
ability of DCs to present antigens, activate lymphocytes, and secrete cytokines, while
miR375 over-expression repressed activation of DCmaturation. Nevertheless, PB1 could
not promote DC maturation once miR375 was inhibited. Finally, we revealed that PB1
inhibited the P-Jnk/Jnk signaling pathway, but activated the p-Erk/Erk signaling pathway.
While inhibition of miR375 -activated the p-Erk/Erk and p-p38/p38 signaling pathway, but
repressed the P-Jnk/Jnk signaling pathway. Taken together, results of our studies shed
new light on the roles and mechanisms of PB1 and miR375 in regulating DC function
and suggest new strategies for combating AIV.
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INTRODUCTION
The influenza virus contains eight segments of a single-stranded RNA genome with negative
polarity. The H9N2 subtype avian influenza virus (AIV), classified as a low pathogenic AIV, has
high genetic variability and has shown both increases in virulence and ability to cross the host
barrier (Peiris et al., 1999; Jin et al., 2014; Shaib et al., 2014; Zhou et al., 2014). Since the H7N9 and
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H10N8 AIV outbreaks in 2013 resulted from recombination
between H9N2 and other influenza subtypes, H9N2 AIV is a
subject of intense research (Fang et al., 2013; Pu et al., 2015).
The virus polymerase complex of H9N2 AIV, consisting of the
polymerase basic protein 1 (PB1), polymerase basic protein 2
(PB2) and polymerase acidic protein (PA) subunits, has been
reported to charge for catalyzing both viral RNA genome
replication and transcription. Previous studies have shown that
PB1 serves as a core subunit to incorporate PA and PB2 into
the polymerase complex by directly interacting with PA and PB2
(Hemerka et al., 2009). Recently studies also reveal that PB1
interacted with PA was an attractive target for drug treatment
(Massari et al., 2016; Swale et al., 2016).
There is a continuing need for novel anti-influenza
therapeutics using new targets or creative strategies and
the pathogenicity of a virus is determined not only by its
characteristics but also by the host immune response (O’Donnell
and Subbarao, 2011). Dendritic cells (DCs) is a professional and
effective antigen-presenting cells in the innate immune response
(Tucci et al., 2014). Influenza virus is a human pathogen
and also naturally infects a large range of animals. Previous
studies have found that the mouse model of influenza virus
infection is useful for understanding host immune responses
and host-pathogen interaction. Zhou found that miR2911,
a honeysuckle (HS)-encoded atypical microRNA (miRNA),
directly targets Influenza A virus with various subtypes (Zhou
et al., 2015). Also, Isakova-Sivak and colleagues have used the
mouse model to study the infectivity, immunogenicity and
cross-protective efficacy of live attenuated influenza vaccines
containing nucleoprotein from cold-adapted or wild-type
influenza virus (Isakova-Sivak et al., 2017). Consequently,
because human blood and humanized mice were not available
for our studies, we developed a suitable animal model to study
AIV responses in mammalian DCs. AIV infection affects the
maturation, antigen presenting ability, and cytokine secretion
of DCs (Lin et al., 2014). The binding of pathogen-associated
molecular patterns to receptors expressed by DCs may activate
DCs (Lopez et al., 2004; Liang et al., 2013), but it remains unclear
how AIVs produce changes in DCs and how DCs respond to
AIV infection.
MicroRNA (miRNA) have emerged as key regulators of innate
immunity and modulate the ability of DCs to present antigens
and secrete cytokines (Gantier et al., 2007; Cheng et al., 2012;
Smyth et al., 2015). For example, miR-24 has been shown to be
regulated during macrophage and dendritic cell differentiation
potentiates innate immunity (Fordham et al., 2015). MicroRNA-
146a reported to regulate human dendritic cell apoptosis and
cytokine production by targeting TRAF6 and IRAK1 proteins
(Park et al., 2015). Furthermore, AIV infection leads to the
differential expression of cellular miRNA in chickens and mice,
and miR491 and miR654 inhibit the replication of H1N1 virus
through binding to PB1 in MDCK cells (Song et al., 2010).
Since miRNA have the ability to modulate DC function, and
our previous research work demonstrated that H9N2 AIV
significantly influenced miRNA expression of DCs, the purpose
of our study was to investigate the role miRNA play in regulating
the immune response of DCs to PB1 stimulation.
RESULTS
miRNA Expression following H9N2 AIV
Infection and Viral Fragment Transfection
To study how H9N2 might control miRNA expression, three
segments of H9N2 AIV (PB1, PA, and NP) were cloned into
pcDNA3.1 and transfected into bone marrow-derived DCs
(BMDCs) (Supplementary Image 1). The expression of selected
miRNAs was then examined by reverse transcription quantitative
real-time PCR (RT-qPCR). Interestingly, for all of the miRNAs
up-regulated by H9N2, PB1, PA, and NP significantly repressed
their expression. For the miRNAs down-regulated by H9N2, the
PB1 segment also mostly reduced their expression, especially for
miR339, miR375, and miR146 (Figures 2A,B). Segments PB1,
PA, and NP are involved in the transcription and replication of
the AIV RNA genome (Bouvier and Palese, 2008).
Activation of Mouse BMDCs by PB1
We first examined the phenotypic changes in BMDCs transfected
with PB1, PA, and NP. The transfection efficiency of PB1,
PA, and NP was detected by RT-qPCR, and results are
listed in Supplementary Data Sheet 1. Fluorescence-activated
cell sorting (FACS) suggested that the mean fluorescence
intensity (MFI) of MHCII was significantly enhanced by PB1,
as were the co-stimulatory molecules CD40, CD80, and CD86
(Figures 3A,B). PA segment up-regulated CD80 and CD86,
whilst NP had no effect on them (Figures 3A,B). Next, we
assessed the ability of DCs to activate T lymphocytes and
secrete cytokines. As shown in Figures 3C,D, PB1-stimulated
DCs showed enhanced stimulation at a ratio of 1:1, and
they expressed higher levels of interleukin-6 (IL-6) and tumor
necrosis factor-α (TNF-α) than did the pcDNA3.1-transfected
controls (P < 0.05). Whilst the LPS stimulation (positive
control) were demonstrated to enhance the ability of DCs
to present antigens, activate T lymphocytes, and secrete
cytokines.
The Immune Function of miR375 and
miR181b in Regulating Mice BMDCs
Recent studies have shown that miRNA regulate the immune
responses of BMDCs (Wu et al., 2012). As H9N2 and
PB1 significantly down-regulated the expression of miR375
(Figure 2), we examined the functions of miR375 in BMDCs.
MiRNA over-expression vectors were constructed and validated
by digesting with restriction enzyme Hind III and BamHI
(Supplementary Image 2). FACS showed that miR375 over-
expression decreased the percentage of CD80-, CD86-, CD40-,
and MHCII when compared with the pSilencer4.1 group. While
inhibition of miR375 greatly down-regulated the MFI of CD80
and CD86, but up-regulated the MFI of CD40 and MHCII
when compared with the blank group (Figures 4A,B). Moreover,
results also shown that the abundance of miR181b significant
down-regulated all the surface -markers except MHC-II.).
Interestingly, we found that the inhibition of miR181b significant
increased theMFI ofMHCII and CD-86 when compared with the
blank group (Figures 4A,B).
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Inhibition of Endogenous miR375 and
miR181b Blocked PB1-Induced Phenotypic
Alterations in BMDCs
Previous studies demonstrated that PB1 and a number of
miRNAs, including miR375 and miR181b, can influence the
phenotype of BMDCs. Thus, we investigated whether the PB1-
induced changes in DCs are mediated by miRNAs. To test this
hypothesis, miRNA inhibitors were added to DCs to repress
endogenousmiRNAs before PB1 transfection. FACS revealed that
the inhibition of endogenousmiR375 andmiR181b decreased the
expression of co-stimulatory molecules (CD80/CD86 and CD40)
andMHCII, whichwas induced by PB1 (P< 0.05; Figures 4C,D).
Effects on Signaling Pathways Stimulated
by PB1, miR375 and miR181b
Mitogen-activated protein kinase (MAPK) pathways exist in all
eukaryotes and control a wide range of cellular processes, such
as proliferation, differentiation, and survival (Kolch, 2000). We
previously demonstrated that H9N2 AIV activates interferon
(IFN) regulatory factor (IRF)-7. In this study, we first found
that PB1 not only significant activated the p-Erk/Erk signaling
pathway, but also inhibited the P-Jnk/Jnk signaling pathway
when compared with the pcDNA3,1 group. Then, we found that
over expressed miR375 significant decreased the expression level
of p-IkBa/IkBa and IRF7, whilst the over expression of miR181b
significant decreased the expression level of p-IkBa/IkBa, IRF3
and IRF7, but significant increased the expression level of p-
Erk/Erk. Furthermore, we found that the inhibition of miR375
hugely up-regulated the expression level of p-p38/p38, p-Erk/Erk
and IRF7, but down-regulated the expression level of p-IkBa/
IkBa and p-Jnk/Jnk which suggested activation of P38, Erk,
NF-κB, and IFN signaling pathway. Finally, the inhibition of
miR181b significant repressed the p-Jnk/Jnk signaling pathway
when compared with the blank group (Figures 5A,B).
DISCUSSION
The interactions between miRNA and DCs are important for
AIV infection. In this report, we focused on miR375, which
exhibited decreased expression in the PB1 segment stimulated
group. DCs play an important role in the generation and
maintenance of immune responses (Smyth et al., 2015). There
are three standards for evaluating the immune function of
BMDCs, including phenotypic alterations, the ability to activate
T lymphocytes and the ability to secrete cytokines (Banchereau
et al., 2000). Our study suggests that the immune function of
DCs, including phenotypic alteration, T lymphocyte activation,
and cytokine secretion, was greatly stimulated by PB1. Also, we
demonstrated that expression of miR375 was suppressed by PB1.
MiRNAs repress key regulatory components of the innate
immune response and markedly affected the capacity of DCs
to present antigens and secrete cytokines. MicroRNA-375
was observed to influence cell proliferation, apoptosis and
differentiation through the Notch signaling pathway, while
microRNA-181b modulated the secretion of TNF-α and IL-1β
in macrophages (Zhang et al., 2015; Wang et al., 2016). Our
research suggests that increased expression of miR375 attenuated
the DC immune responses induced by PB1. PB1 over-expression
increased the levels of CD80-, CD86-, MHCII-, and CD40 in
cultured BMDCs, whilst the inhibition of endogenous miR375
had the opposite effect (Figures 4C,D). MiR375 also modestly
decreased the expression of CD80; this effect was reversed by
inhibiting endogenous miR375. Also, miR181b repressed the
expression of CD40 and MHCII; this inhibition effect was
relieved when endogenous miR181b was silenced. All four
surface markers are characteristics of fully mature DCs and
represent different functionalities (Geissmann et al., 2010). The
major histocompatibility complex class II (MHCII) are family
of molecules normally found on antigen-presenting cells such
as DCs and mononuclear phagocytes. The MHCII-dependent
pathway of antigen presentation is called the exogenous pathway,
which has been shown to be regulated by miRNAs (Tomasi
et al., 2010). Over-expression of PB1 enhances the ability of
DCs to express the surface markers, activate lymphocytes and
secrete inflammatory cytokines. Whilst the addition of miR181b
decreased the expression of MHCII and CD40, this effect can be
repressed by inhibiting expression of miR181b. Thus, miR181b
may enhance the function of DC by down-regulating surface
maturation molecules MHCII. PB1 increased the expression of
the pro-inflammatory cytokines IL-6 and TNF-α, but had no
effect on the anti-inflammatory cytokines IL-10 and IL-12, which
seem to trigger Th17 programming in the BMDC. DCs also
promote Th1 responses via IL-12 (de Jong et al., 2002).
IFN-α, controlled primarily by IFN regulatory factor 3 (IRF-
3) and IFN regulatory factor (IRF-7), plays a crucial role in host
defense processes against viral infection (Taniguchi and Takaoka,
2002; Yanai and Taniguchi, 2008). H9N2 AIV infection could
result in the activation of IRF-7 on DCs (Lin et al., 2014). Our
results show that IRF-3 and IRF-7 were all down-regulated in
miR375 and miR181b groups, while inhibition of endogenous
miR375 and miR181b significantly decreases IRF-3 and IRF7,
suggesting that miR375 and miR181b are necessary for the
production of IFN-α.
In summary, our results suggest that on the one hand, H9N2
virus protein PB1 can enhance the ability of DC to induce
their phenotype, activate lymphocytes and secrete cytokines,
and this effect may be accomplished by reducing the Jnk
signaling pathway and activating the Erk signaling pathway.
On the other hand, our results also suggest that miR375 can
inhibit maturation of DC by decreasing expression of surface
markers. Here, we demonstrated a previously unidentified role
for PB1 in the regulation of murine immune responses of DCs,
which was mediated by miR375 and miR181b. We propose
that PB1 may enhance the function of DC by down-regulating
miR375. Thus, miR375 may have a previously uncharacterised
immunomodulatory role that can activate DCs for defense
against H9N2 AIV (Figure 1).
METHODS
Ethics Statement
SPF C57BL/6 and BALB/c mice were obtained fromComparative
Medical Center of Yang Zhou University. This study was
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FIGURE 1 | Summary of the research strategy.
FIGURE 2 | Results of the qPCR analysis of select miRNAs following stimulation by PB1, PA, or NP. (A) The expression levels of down-regulated miRNAs
stimulated by PB1, PA, or NP (*P < 0.01, the significance of the data was determined by one-way ANOVA with Duncan test) (CK: blank DCs; PB1, PA, and NP:
plasmid over-expressed DCs; LPS: 1µg/ml, each times, three 4–6 week wild-type male C57BL/6 mice were sacrificed to isolated BMDCs and experiments were
performed at least in triplicate). (B) The expression levels of up-regulated miRNAs stimulated by PB1, PA, or NP (*P < 0.01, the significance of the data was
determined by one-way ANOVA with Duncan test) (CK: blank DCs; PB1, PA, and NP: plasmid over-expressed DCs; LPS: 1µg/ml).
approved by the Ethical Committee of Animal Experiments
of the College of Veterinary Medicine, Nanjing Agricultural
University. All animal care and use were conducted in strict
accordance with the Animal Research Committee guidelines
of the College of Veterinary Medicine, Nanjing Agricultural
University.
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FIGURE 3 | Immune activation of BMDCs stimulated by PB1. (A) Flow cytometric analysis of the phenotypic alterations in DCs stimulated with PB1, PA, or NP
(i.e., the expressions of CD40, CD80/86, and MHCII on BMDCs stimulated with PB1, PA, or NP). (Isotype: IgG2a for CD40, IgG1 for CD80, and CD86, IgG2b for
MHCII; Blank: DCs without any treatment; Lipo: DCs added the same lipofectame as transfection groups; PB1, PA, and NP: plasmids transfected DCs; pcDNA3.1
group: plasmid pcDNA3.1 transfected DCs; LPS: Positive control, 1µg/ml LPS, three 4–6 week wild-type male C57BL/6 mice were sacrificed to isolated BMDCs and
experiments were performed at least in triplicate). (B) The MFI of CD40, CD80/86, and MHCII (*P < 0.05, **P < 0.01, or ***P < 0.001 the significance of the data was
determined by one-way ANOVA with Tukey’s multiple comparison test). (C) PB1-stimulated BMDCs stimulated the proliferation of naive T cells in mixed-lymphocyte
reactions (MLR). The stimulator cells were BMDCs stimulated with or without PB1, pcDNA3.1, or LPS at 37◦C for 24 h. All experiments were performed at least in
triplicate. Significant differences between the treated and pcDNA3.1 groups are expressed as *P < 0.05 or **P < 0.01. The significance of the data was determined by
one-way ANOVA with Tukey’s multiple comparison test. (D) Cytokine release from PB1-stimulated BMDCs was measured by enzyme-linked immunosorbent assays
(ELISAs). Data for IL-6, IL-10, IL-12, and TNF-α are shown as means ± standard deviation (SD) of three samples. Significant differences between the treated and
pcDNA3.1 groups are expressed as *P < 0.05 or **P < 0.01. The significance of the data was determined by one-way ANOVA with Tukey’s multiple comparison test.
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FIGURE 4 | The immune function of BMDCs stimulated by miR375 andmiR181b. (A) Flow cytometric analysis of the phenotypic alterations in DCs stimulated
by miR375, miR181b, In-miR375, and In-miR181b (i.e., the expressions of CD40, CD80/86, and MHCII on BMDCs stimulated by miRNAs). (Isotype: IgG2a for CD40,
IgG1 for CD80 and CD86, IgG2b for MHCII; Positive control, 1µg/ml LPS, three 4–6 week wild-type male C57BL/6 mice were sacrificed to isolated BMDCs and
experiments were performed at least in triplicate). (B) The MFI of CD40, CD80/86, and MHCII. (*P < 0.05, **P < 0.01, or ***P < 0.001 the significance of the data was
determined by one-way ANOVA with Tukey’s multiple comparison test). (C) PB1 mediated BMDCs activation when miR375 and miR181b were inhibited (100µg/ml
inhibitor for each miRNA, Isotype: IgG2a for CD40, IgG1 for CD80 and CD86, IgG2b for MHCII, three 4–6 week wild-type male C57BL/6 mice were sacrificed to
isolated BMDCs and experiments were performed at least in triplicate). (D) The MFI data for CD40, CD80/86, and MHCII. (*P < 0.05, **P < 0.01, or ***P < 0.001 the
significance of the data was determined by one-way ANOVA with Tukey’s multiple comparison test).
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FIGURE 5 | Regulatory protein expression on BMDCs stimulated by PB1 and miRNAs as determined by Western blotting. (A) Western blot results for
IkBa, P38, ERK, Jnk, IRF-3, and IRF-7 in cells stimulated by PB1, miR375 and miR181b (lane 1: blank group; lane 2: pcDNA3.1 stimulated group; lane 3: PB1
stimulated group; lane 4: pSilencer4.1 stimulated group; lane 5: miR375 stimulated group; lane 6: miR181b1 stimulated group; lane 7: InmiR375 stimulated group;
lane 8: In-miR181b1 stimulated group; three 4–6 week wild-type male C57BL/6 mice were sacrificed to isolated BMDCs and experiments were performed at least in
triplicate). (B) The expression levels of IkBa, P38, ERK, Jnk, IRF-3, and IRF-7 in cells stimulated by PB1, miR375 and miR181b (the data shown are the
means ± standard error of the mean of double wells from three independent experiments). The levels of significance are identified by *P < 0.05, **P < 0.01, or
***P < 0.001.
Plasmids and Cell Culture
Three RNA segments that encode proteins involved in viral
replication (PB1, PA, and NP) were amplified from the H9N2
virus and cloned into pcDNA3.1 (Invitrogen). MiRNAs (miR-
375 and miR-181) were amplified and cloned into pSilencer4.1
(Invitrogen). Bone marrow-derived dendritic cells (BMDCs)
were prepared from the femurs and tibias of sacrificed 4–6
week wild-type male C57BL/6 mice and treated with red blood
cell lysis buffer (Beyotime) (Lin et al., 2014). Briefly, bone
marrow cells were flushed from the tibias and femurs and
cultured in complete medium (RPMI1640 (Invitrogen) with
10% FBS (Hyclone), 1% streptomycin and penicillin, 10 ng/ml
recombinant granulocyte-macrophage colony-stimulating factor
(GM-CSF) and IL-4 (Peprotech) and plated in 6-well plates.
At day 6, the non-adherent, relatively immature DCs (1 × 106
cells/ml) were harvested and centrifuged to remove debris
and dead cells, then cultured overnight in complete medium
and transfected with different plasmids for subsequent assays.
Transferred cell samples (1 × 106 cells) were washed twice
with PBS and incubated at 4◦C for 30 min with the following
monoclonal antibodies (anti-mouse CD11c (N418), anti-mouse
CD40 (1C10), anti-mouse CD86 (GL1), anti-mouseMHC (major
histocompatibility complex) class II (M5/114.15.2) and anti-
mouse CD80 antibody (16-10A1), respectively (eBioscience).
Finally, cells were analyzed using a Fluorescence Active Cell
Sorter (FACS) (BD, FACS Aria) after two separate washes.
The Choice of miRNAs and Quantitative
PCR Validation
To test which viral protein had the largest effect on expression of
miRNAs, we amplified three replication related RNA segments
(PB1, PA, and NP) and then cloned these into pcDNA3.1
vector. Primers are listed in Supplementary Table 1. Based on
the microarray result, 9 up-regulated and 8 down-regulated
genes were selected for RT-qPCR verification. Small RNAs
were purified using the miRNeasy mini kit (Qiagen) and
reverse transcribed to cDNA by miScript Reverse Transcriptase.
QuantiTect SYBR Green PCR master mix (Qiagen) was used
to perform qPCR according to the manufacturer’s instructions.
miRNA expression was normalized to the internal control
5S rRNA. Primers for 17 selected miRNAs are listed in
Supplementary Table 2. All assays were performed in triplicate.
Relative expression levels were calculated using the 2-11Ct
method (Livak and Schmittgen, 2001).
Immune Response of BMDCs Stimulated
by PB1
Surface Marker Alterations of BMDCs
Immature BMDCs were plated into fresh medium (1 × 106
cells/ml) and transfected with one of the three vector
constructs(PB1, PA, and NP), pcDNA3.1 (negative control)
and LPS (1µg/ml, positive control) for 48 h. Then cell samples
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(1× 106 cells, 1.5 ml tube) were collected, washed twice with PBS
and incubated at 4◦C for 30 min with the following monoclonal
antibodies (anti-mouse CD11c, anti-mouse CD40, anti-mouse
CD86, anti-mouse MHC class II and anti-mouse CD80 antibody
or the respective isotype controls, respectively). After washing,
cells were analyzed with a Fluorescence Activated Cell Sorter
(FACS) (BD, FACS Aria)
Allogeneic Mixed Leukocyte Reaction (MLR)
Proliferation Assays
The primary T-cell stimulatory capacity of BMDCswas examined
in a MLR. Untreated and variously treated BMDCs [pcDNA3.1-
stimulated, PB1-stimulated and LPS-stimulated (1µg /ml)] were
used as the stimulator cells. Allogeneic lymphocytes were
obtained from BALB/c mice as follows. Leukocytes were isolated
from the spleens of 4 to 6 week-old allogeneic BALB/c mice with
a T cell isolation kit (Miltenyi, Bergisch Gladbach, Germany) and
cultured in complete RPMI 1640 medium supplementaryed with
10% FCS in 96-well plates at 37◦C for 48 h. Graded numbers
of responder cells (1 × 105 cells/well) were added to 96-well
round bottomed plates, giving responder: stimulator ratios of 1:1
or 5:1, in a culture volume of 100µl. Cell proliferation assays
was conducted with the Cell Counting Kit-8 (CCK-8, Beyotime).
Each well received 20µl CCK-8 solution and was incubated for a
further 2 h at 37◦C before absorbance measurement at 450 nm.
All experiments were conducted in triplicate. The Stimulation
Index was calculated using the formula:
SI = (ODsample −ODstimulator cells only)/
(ODresponder cells only −ODblankcontrol).
Cytokine Analysis
Bone marrow-derived dendritic cells (BMDC) culture
supernatants were collected at 24 h after treatments (Groups were
divided as MLR experiments). Concentrations of TNF-α, IL-6,
IL-10, and IL-12p70 in the supernatants were measured using
the Quantikine Elisa kit (Boster) according to the manufacturer’s
instructions. The sensitivity of the assay was 2 pg/ml for TNF-α,
and 4 pg/ml for IL-6, IL-10, and IL-12p70.
qRT-PCR Validation
BMDCs was cultured and collected at 24 h after treatments with
PB1, PA and NP segments. qPCR was conducted to examine
expression variation for selected genes. Individual samples were
diluted 1:5 and 2µl was amplified in a 20µl reaction containing
10µl of SYBR PremixTM Ex Taq (TaKaRa), 0.4µl of ROX dye
II and 0.4µM of each of the forward and reverse gene-specific
primers using an ABI 7500 instrument (Applied Biosystems,
USA). - We also evaluated the transcription efficiency of plasmid
pcDNA3.1-PA, NP, and PB1 by qPCR. Primers are- listed in
Supplementary Table 3.
Immune Response of BMDCs Stimulated
with miRNAs
Plasmid Construction and Phenotypic Detection
To confirm that the phenotype alteration induced by PB1 is
meditated by miRNA, miRNA over-expression vectors were
constructed using the pSilencer4.1 vector (Invitrogen). Four
selected miRNAs (miR375 and miR181b) were amplified
and then cloned into pSilencer4.1. Primers are listed in
Supplementary Table 4. The isolation of BMDCs and
phenotypic detection were performed as described above
Plasmids were transfected with lipofectame2000 reagent
(Invitrogen). MiR181b and miR375 inhibitors, which were
chemically modified single stranded RNAs, were designed
and purchased from RiboBio to evaluate miRNA function
(Guangzhou, China). Each 100 nM miRNA inhibitor
(micrOFFTM mmu-miR-181b-3p inhibitor, micrOFFTM mmu-
miR-375-5p inhibitor, and micrOFFTM inhibitor Negative
Control) was transfected into BMDCs for 24 h to analyze their
effect on DCs via detection of- phenotypic alteration with FACS.
miRNA Inhibition Experiment
To detect whether the phenotypic alteration of BMDCs induced
by PB1 was mediated by miR181b or miR375, miRNAs inhibitors
were transfected into BMDCs for 4 h as described above, before
PB1 over-expression plasmid was transfected. After another
24 h, BMDCs were collected for phenotypic detection using
FACS.
Western Blot Assay
MAPK, NF-kB, and IFN-a signaling pathways control a wide
range of cellular processes, especially for the immune response.
Thus, we tried to evaluated how PB1 and their induced miRNAs
affect the MAPK, NF-kB, and IFN-a signal pathways by western
blot. BMDCs were transfect with PB1, miR375, miR181b, In-
miR375, and In-miR181b for 48 h. Then cells were collected
and washed with PBS three times for the next experiments.
Western blot detection was performed as previously described by
us. Mouse IkBa, P-IkBa, P38, P-P38, ERK, P-ERK, JUK, P-JUK,
IRF-3, and IRF-7 were purchased from Abcam or Cell Signaling
Technology and detected according to each manufacturer’s
protocol. Protein bands were visualized using the Super ECL Plus
system. GAPDH was used as a loading control (Abcam).
Statistical Analyses
Data were evaluated by unpaired two-tailed Student’s t-test using
GraphPad Prism 5 (http://www.graphpad.com) (CSSN), with
p< 0.05 considered to be statistically significant. The significance
of the data was also determined by one-way ANOVA, followed
by Tukey’s multiple comparison tests. FACS data were analyzed
by FlowJo software (FlowJo, China). All data are expressed as
mean± standard error of the mean.
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Supplementary Image 1 | Identification and construction of
pcDNA3.1-PB1, pcDNA3.1-PA, and pcDNA3.1-NP. (A) Identification of
pcDNA3.1-PB1 by digestion with XhoI and KpnI (M1: DL5000 DNA marker; 1:
plasmid pcDNA3.1-PB1; 2: plasmid pcDNA3.1-PB1 digested with XhoI and KpnI).
(B) Identification of pcDNA3.1-NP by digestion with XhoI and HindIII (M1: DL5000
DNA marker; 1: plasmid pcDNA3.1-NP; 2: plasmid pcDNA3.1-NP digested with
XhoI and HindIII). (C) Identification of pcDNA3.1-PA by digestion with XhoI and
HindIII (M1: DL5000 DNA marker; 1-3: plasmid pcDNA3.1-PA digested with XhoI
and HindIII; 4: plasmid pcDNA3.1-PA).
Supplementary Image 2 | Identification and construction of
pSilencer-miR375 and pSilencer-miR181b by digestion with BamHI and
HindIII. (A) Identification of pSilencer-miR181b by digestion with BamHI and
HindIII (M1: DL5000 DNA marker; 1: plasmid pSilencer- miR181b; 2:
pSilencer-miR181b digested with BamHI and HindIII). (B) Identification of
pSilencer-miR375 by digestion with BamHI and HindIII (M1: DL5000 DNA marker;
1: pSilencer-miR375 digested with BamHI and HindIII; 2: plasmid
pSilencer-miR375).
Supplementary Table 1 | Primers used in amplified PB1, PA and NP.
Supplementary Table 2 | qRT-PCR primers used for detecting miRNAs
alteration.
Supplementary Table 3 | qRT-PCR primers used for detecting target genes
and viral segments.
Supplementary Table 4 | Primers used in amplified miR375 and miR181b1.
Supplementary Data Sheet 1 | Results of the qPCR analysis of the
transfection efficient on BMDCs with plasmid pcDNA3.1-PA,
pcDNA3.1-NP and pcDNA3.1-PB1.
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